Similarly, mutations in AML-related genes, such as NPM1 and FLT3, although very rare, can be acquired during the course of the disease and are highly suggestive of AML transformation [86,87] (Figure 3A). This evidence concerns the gene FLT3 and acute myeloid leukemia.